| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067521 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7pyridinyl-imidazo[1,2-alpha]pyrimidin-5(1H)-one derivatives |
| 06/27/2006 | US7067520 Antidiabetic agents; hypoglycemic agents; antilipemic agents; dietetics |
| 06/27/2006 | US7067519 human orexin receptor antagonists; analgesics, antidiabetic agents; sleep apnea, insomnia |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067511 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease |
| 06/27/2006 | US7067114 Delivery of antihistamines through an inhalation route |
| 06/22/2006 | WO2006065919A1 Pyridil-substituted spiro-hydantoin compounds and use thereof |
| 06/22/2006 | WO2006065908A1 Crystalline forms of6- [(5s, 9r) -9- (4-cyanophenyl) -3-(3, 5-dichlorophenyl) -1-methyl-2, 4-dioxo-1, 3, 7-triazaspiro [4.4] non-7-yl] nicotinic |
| 06/22/2006 | WO2006065703A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | WO2006065480A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | WO2006064205A2 Process for the preparation of a boron-substituted porphyrin |
| 06/22/2006 | WO2006064196A1 Pyrazolopyrimidine compounds as antitumor agents |
| 06/22/2006 | WO2006063820A1 Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases |
| 06/22/2006 | WO2006063709A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer’s disease |
| 06/22/2006 | WO2006063708A1 Tetracyclic imidazo-benzodiazepines as gaba receptors modulators |
| 06/22/2006 | WO2006036883A3 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases |
| 06/22/2006 | WO2005080397A8 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
| 06/22/2006 | US20060135767 Dipeptidyl peptidase inhibitors |
| 06/22/2006 | US20060135658 Containing a bis{[benzo[4,5]imidazo[2,1-a]isoindolyl]-11-one and optionally a polymer; preparation from an o-phenylenediamine and a bis(phthalic anhydride) or a bis(o-phenylenediamine) and a phthalic anhydride |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135575 2-Acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135540 PPAR active compounds |
| 06/22/2006 | US20060135538 7-(R)-aminotriazolopyrimidines, their preparation and their use for controlling phytopathogenic fungi |
| 06/22/2006 | US20060135537 Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases |
| 06/22/2006 | US20060135526 Pyrazolo [1,5-A] pyrimidine adenosine A2a receptor antagonists |
| 06/22/2006 | US20060135525 Pyrazolopyrimidine compound and a process for preparing the same |
| 06/22/2006 | US20060135517 Imidazolopyridines and methods of making and using the same |
| 06/22/2006 | US20060135514 Pyrazolo[1,5-a]pyrimidine derivatives |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135501 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors |
| 06/22/2006 | US20060135478 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 06/22/2006 | US20060135367 2,5 -Difluoro-N-isobutyl-N-(8-propyl-[1,2,4]triazolo,[1,5-c]pyrimidin-7-ylmethyl)-benzamide; gamma aminobutyric acid receptor (GABAR) agonist/antagonist; anxiolitic, antidepressant; sleep disorder, attention deficit disorder, schizophrenia or Alzheimer's dementia |
| 06/22/2006 | US20060134764 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 06/22/2006 | CA2591042A1 Process for the preparation of a boron-substituted porphyrin |
| 06/22/2006 | CA2590333A1 Tetracyclic imidazo-benzodiazepines as gaba receptors modulators |
| 06/22/2006 | CA2590316A1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease |
| 06/22/2006 | CA2590294A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | CA2589051A1 Trycyclic heterocycles, their manufacture and use as pharmaceutical agents |
| 06/22/2006 | CA2588384A1 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | CA2586543A1 Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases |
| 06/21/2006 | EP1671972A1 Octahydropyrrolo[3,4-c]pyrrole derivatives |
| 06/21/2006 | EP1671962A1 Novel fused heterocyclic compound and use thereof |
| 06/21/2006 | EP1670803A1 Certain substituted spirocyclic lactams and use thereof as pharmaceuticals |
| 06/21/2006 | EP1670802A2 Novel heterocyclic compounds as hsp90-inhibitors |
| 06/21/2006 | EP1670801A1 Pyrazolo and imidazo-pyrimidine derivatives |
| 06/21/2006 | EP1670800A1 Ceratamines a and b, and analogues, syntheses and pharmaceutical compositions thereof |
| 06/21/2006 | EP1670793A1 Antibacterial agents |
| 06/21/2006 | EP1670791A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 06/21/2006 | EP1670787A2 Cytokine inhibitors |
| 06/21/2006 | EP1670313A1 Fungicidal mixtures |
| 06/21/2006 | EP1362049B1 Pyrazolo-triazoles and use of said compounds for dyeing keratinous fibres |
| 06/21/2006 | EP1255734B1 Isatine derivatives with neurotrophic activity |
| 06/21/2006 | EP1100770B1 Monomers and network polymers obtained therefrom |
| 06/21/2006 | CN1791604A Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 06/21/2006 | CN1791603A Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 06/21/2006 | CN1791594A 2-aminoquinoline derivative |
| 06/21/2006 | CN1791410A Methods for treating or preventing an inflammatory or metabolic condition by inhibiting JNK |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 06/20/2006 | US7064212 Dicationic viologens, such as methyl viologen and benzyl viologen, associated with anions selected from bis(trifluoro-methyl(or perfluoroethyl)sulfonyl)imide and tris(trifluoro-methylsulfonyl)methide; soluble in quat ammonium melts |
| 06/20/2006 | US7064204 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders |
| 06/20/2006 | US7064203 Di-substituted pyrrolotriazine compounds |
| 06/20/2006 | US7064202 Camptothecin intermediates and prodrugs and methods of preparation thereof |
| 06/20/2006 | US7064201 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064120 For prevention and/or suppression of preterm labor, suppression of labor at term prior to caesarean delivery, and for the treatment of dysmenorrhea; useful in enhancing fertility rates |
| 06/20/2006 | US7064119 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 06/20/2006 | US7063832 Treating musculoskeletal pain or restless leg syndrome by breathing a muscle relaxant condensation aerosol having a mass median aerodynamic diameter (MMAD) of <3 mu m and <5% relaxant degradation products; kits; heating a coating of drug on a support to vaporize and passing air through the heated vapors |
| 06/20/2006 | US7063831 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/20/2006 | US7063830 condensation aerosol for delivery of lidocaine, verapamil, diltiazem, isometheptene and lisuride, wherein aerosol is formed by heating a thin layer containing the drug, on a solid support, to produce a vapor of the drug, and condensing the vapor to form aerosol |
| 06/20/2006 | US7063806 use in preparation of inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, or in preparation of polymeric ink particles, toners, dye lasers and electroluminescent devices; lightfastness, high heat stability, high in efficiency of electrical energy |
| 06/20/2006 | CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2379585C Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2177392C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 06/15/2006 | WO2006062465A1 Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy |
| 06/15/2006 | WO2006061415A1 2,4 (4,6) pyrimidine derivatives |
| 06/15/2006 | WO2006061392A2 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 06/15/2006 | WO2006061212A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 06/15/2006 | WO2005113526A3 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one |
| 06/15/2006 | US20060128969 Polymerization of substituted indolocarbazoles, a reaction medium, and a coupling agent of FeCl3, FeBr3, Fe2(SO4)3, RuCl3, MoCl5, Na2S2O8, K2S2O8, K2Cr2O7, KMnO4, KBrO3, and KClO3; liquid-processable and air stable organic semiconductor compounds to enable low-cost Organic Thin Film Transistors |
| 06/15/2006 | US20060128968 A novel intermediate, 2-butyl-3-(4'bromobenzyl)-1,3-diazaspiro[4.4]non-1-ene-4-one; a Suzuki coupling reaction with a protected imidazolephenylboronic acid will give irbesartan |
| 06/15/2006 | US20060128967 a chemical intermediate to irbesartan, by reacting a valerimidate derivative with a first amine using acid catalyst, cooling, reacting with a second amine and second acid catalyst, heating to reflux, contacting with base, phase separation and recovery |
| 06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/15/2006 | US20060128903 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/15/2006 | US20060128785 diindole compounds as anticancer agents; potentiation; effective against estrogen-dependent, estrogen-independent, drug-resistant and/or metastasized cancers |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128761 Novel triazole compounds as transforming growth factor (TGF) inhibitors |
| 06/15/2006 | US20060128756 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| 06/15/2006 | US20060128749 Compounds |
| 06/15/2006 | US20060128748 Bicyclic triazole alpha4 integrin inhibitors |
| 06/15/2006 | US20060128732 enzyme inhibitor of phosphotidylinositol-3-kinase (PI3K); N-(7,8-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)nicotinamide; antiinflammatory agent, immunomodulators; asthma, dermatitis, rhinitis, allergic diseases, chronic obstructive pulmonary disease, rheumatoid arthritis, Graves' disease |
| 06/15/2006 | US20060128731 Parkinson's disease; antidepressants; cognition activators; attention deficit disorders; narcolepsy; N,N-dimethyl-4-(2-furyl)-1H-pyrrolo[2,3- d]pyrimidine-2-amine |
| 06/15/2006 | US20060128729 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 06/15/2006 | US20060128728 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors |
| 06/15/2006 | US20060128726 Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulations |
| 06/15/2006 | US20060128725 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |